Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.
J Infect Dev Ctries
; 5(5): 406-9, 2011 May 28.
Article
in En
| MEDLINE
| ID: mdl-21628821
ABSTRACT
Cutaneous aspergillosis is very rare and occurs predominantly in immunocompromised patients including transplant recipients. We report a 26-year-old male with acute lymphoblastic leukemia who developed cutaneous aspergillosis after undergoing combined immunosuppressive treatment including corticosteroid, cyclosporine A, mychophenolate mofetil and mesenchymal stem cells for steroid refractory skin acute graft versus host disease after myeloablative haematopoietic stem cell transplantation. The patient was treated with oral voriconazole therapy and recovered partially.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Aspergillosis
/
Dermatomycoses
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Immunosuppressive Agents
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
J Infect Dev Ctries
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2011
Document type:
Article
Affiliation country:
Turkey